← The Lantern · New Carlisle
health · class i

Edwards Lifesciences, LLC recalls Optisite Arterial Cannula

The stated reason: due to complaints received for 3mm to 4mm section wire exposed/protruding from the outside of the cannula body.

Illustration: a small clinic exam room with an exam table, a stethoscope and a clipboard
Illustration · The Lantern

Edwards Lifesciences, LLC began a medical device recall on May 14, 2025 whose reported distribution included Ohio. FDA

What the record shows

FDA graded it Class I — a reasonable probability that use will cause serious health consequences or death. Quantity affected: 27022. The recall is listed as ongoing. FDA

1 source

Context

This is one of 3 records of this type (Class I) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2880 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: May 14, 2025 FDA
  • Recall number: Z-2080-2025 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: Edwards Lifesciences, LLC FDA
  • Product: Brand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI16 Software… FDA
  • Reason for recall: due to complaints received for 3mm to 4mm section wire exposed/protruding from the outside of the cannula body. FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

Sources

1Edwards Lifesciences, LLC recalls Optisite Arterial CannulaFDA Recalls — Distributed in Ohio · May 14, 2025 · the filing on this pagefda.gov (opens the agency's page)

The source filing

Recall numberZ-2080-2025
Recalls in this action1
Recalling firmEdwards Lifesciences, LLC
ProductBrand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI16 Software Version: N/A Product Description: Cardiac cannula. The Edwards OptiSite Arterial Perfusion Cannluae provides or establishes arterial perfusion in the extracorporeal circuit for d 6 hours. Component: No.
Reason for recalldue to complaints received for 3mm to 4mm section wire exposed/protruding from the outside of the cannula body.
ClassificationClass I — a reasonable probability that use will cause serious health consequences or death
Recall typemedical device
Quantity27022
StatusOngoing
Voluntary or mandatedVoluntary: Firm initiated
Initiated20250514
Reported20250716
DistributionWorldwide - US Nationwide distribution including in the states of ALABAMA, ARIZONA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, HAWAII, IDAHO, ILLINOIS, INDIANA, IOWA, KANSAS, KENTUCKY, LOUISIANA, MAINE, MARYLAND, MASSACHUSETTS, MICHIGAN, MINNESOTA, MISSISSIPPI, MISSOURI, MONTANA, NEBRASKA, NEVADA, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEW Y
Firm locationIrvine, CA, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.